sorafenib has been researched along with Opportunistic Infections in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carbotti, M; Coppola, R; De Florio, L; Galati, G; Graziano, A; Panasiti, V; Rinati, MV; Zanframundo, S | 1 |
1 other study(ies) available for sorafenib and Opportunistic Infections
| Article | Year |
|---|---|
Rhodotorula mucilaginosa skin infection in a patient treated with sorafenib.
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Dermatomycoses; Humans; Liver Neoplasms; Male; Niacinamide; Opportunistic Infections; Phenylurea Compounds; Rhodotorula; Sorafenib | 2015 |